Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2019

Study Completion Date

October 31, 2019

Conditions
Advanced CancerOvarian CancerEndometrial CancerBreast Cancer
Interventions
DRUG

PM01183 + olaparib

Trial Locations (6)

14004

RECRUITING

Hospital Reina Sofía, Córdoba

28034

RECRUITING

Hospital Ramón y Cajal, Madrid

28046

RECRUITING

Hospital La Paz, Madrid

39008

RECRUITING

Hospital Marqués de Valdecilla, Santander

46009

RECRUITING

Fundación Instituto Valenciano de Oncología, Valencia

08035

RECRUITING

Hospital Universitario Vall d'Hebron, Barcelona

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

PharmaMar

INDUSTRY

lead

Poveda, Andrés, M.D.

INDIV